Drugs in Context

Drugs Context

1745-1981

1740-4398

Therapeutic Area

Cardiology, Clinical Pharmacology, Dermatology, Endocrinology/Metabolism, Gastroenterology, Health Economics/Outcomes Research, Hematology, Immunology, Infectious Diseases, Molecular Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Pharmacology, Primary Care, Psychiatry, Respiratory Care, Rheumatology, Urology

Biomedical Researchers, Health Scientists, Nurse Practitioners, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Physicians, Physicians - Medicine, Researchers

Drugs in Context is an open access, peer-reviewed, continuous publication of international standing. Aim: primarily publishes high-quality, peer-reviewed original research papers and topical review articles covering the latest evidence and innovations in drug treatment across all therapeutic areas. Scope: covers all phases of original research: laboratory, animal and human/clinical studies, health economics and outcomes research, and postmarketing studies. Original research that shows positive or negative results are welcomed. Review articles may cover single-drug reviews, drug class reviews, latest advances in drug therapy, therapeutic-area reviews, place-in-therapy reviews, new pathways and classes of drugs. In addition, systematic reviews and meta-analyses are welcomed and may be published as original research if performed per accepted guidelines. Editorials of key topics and issues in drugs and therapeutics are welcomed. The Editor-in-Chief will also consider manuscripts of interest in areas such as technologies that support diagnosis, assessment and treatment.

No associations affiliated with this journal

Bioexcel Publishing Limited

Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines